Clinical TrialsSearch results
Number of results: 521
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy (SKYSCRAPER-15)
- Non-small Cell Lung Cancer (NSCLC)
- Raymond Meng
- 2024-03-14
Other
- A Phase I Study of Concurrent Chemotherapy using TS-1 with Involved Field Radiotherapy for Elderly Patients with Non-Small Cell Lung Cancer.
- Non-Small Cell Lung Cancer
- Hiroshima Radiation Oncology Study Group
- 2009-07-03
Other
- Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study.
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-07-23
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Not yet recruiting
- Phase 3 study of Adjuvant V940 and Pembrolizumab in Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Fujita Tomoko
- 2024-10-08
Recruiting
- A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDP
- non-small cell lung cancer
- Kyushu University,Graduate School of Medical Science,Department of Surgery and Science
- 2009-03-12
Recruiting
- Phase II study of combination treatment of nivolumab and TM5614 for non-small cell lung cancer (TM-Uprise Study)
- non-small cell lung cancer
- Hattori Noboru
- 2023-07-19
Other
- Gefitnib monotherapy in patients with post-operative recurrent non-small-cell lung cancer with the EGFR mutation: a Phase II study
- non small cell lung cancer with EGFR mutation
- Okayama University Cancer and Thoracic Surgery
- 2006-04-24
Other
- A randomized controlled Phase II study comparing TS-1 alone with CDDP+TS-1 as postoperative adjuvant chemotherapy in non-small-cell-lung-cancer ; translational research of the chemotherapy effect prediction factor
- Non Small Cell Lung Cancer
- West Japan Oncology Group
- 2009-01-26
Other
- An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapse
- non small cell lung cancer
- Okada Morihito
- 2019-06-18